LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces Quarterly Dividend of $0.25

LeMaitre Vascular, Inc. (NASDAQ:LMAT) declared a quarterly dividend on Thursday, February 19th. Shareholders of record on Thursday, March 12th will be given a dividend of 0.25 per share by the medical instruments supplier on Thursday, March 26th. This represents a c) dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Thursday, March 12th. This is a 25.0% increase from LeMaitre Vascular’s previous quarterly dividend of $0.20.

LeMaitre Vascular has increased its dividend by an average of 0.2%annually over the last three years and has raised its dividend every year for the last 14 years. LeMaitre Vascular has a dividend payout ratio of 42.0% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect LeMaitre Vascular to earn $2.17 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 46.1%.

LeMaitre Vascular Stock Up 2.5%

LMAT opened at $110.07 on Tuesday. LeMaitre Vascular has a one year low of $71.42 and a one year high of $115.33. The company has a debt-to-equity ratio of 0.43, a quick ratio of 10.95 and a current ratio of 12.89. The business’s 50-day simple moving average is $89.84 and its 200-day simple moving average is $88.81. The stock has a market capitalization of $2.51 billion, a P/E ratio of 43.85, a price-to-earnings-growth ratio of 3.09 and a beta of 0.66.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings results on Wednesday, February 25th. The medical instruments supplier reported $0.68 EPS for the quarter, beating the consensus estimate of $0.67 by $0.01. LeMaitre Vascular had a return on equity of 14.72% and a net margin of 23.13%.The company had revenue of $64.45 million during the quarter, compared to analysts’ expectations of $62.98 million. During the same quarter in the previous year, the business earned $0.49 EPS. The firm’s revenue was up 15.7% on a year-over-year basis. LeMaitre Vascular has set its FY 2026 guidance at 2.810-3.010 EPS and its Q1 2026 guidance at 0.640-0.690 EPS. Analysts anticipate that LeMaitre Vascular will post 1.94 EPS for the current year.

About LeMaitre Vascular

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.